{"name":"EYE XCEL LIMITED","company_number":"05814814","status":"Active","type":"Private Limited Company","incorporated":"2006-05-12","dissolved":null,"registered_office":"35 Queensway, Stevenage, Hertfordshire, SG1 1BS","postcode":"SG1 1BS","sic_codes":[{"code":86900,"description":"Other human health activities"}],"principal_activity":"The principal activity of the company is optometry and the sale of spectacles.","previous_names":[{"name":"SQUARE SCREEN LIMITED","changed_on":"2006-06-23"}],"warnings":[],"accounts":{"category":"Total Exemption Full","year_end":"28 September","last_made_up_to":"2025-09-30","next_due":"2027-06-28"},"employees":{"count":9,"accounts_date":"2025-09-30"},"financials":[{"financial_date":"2025-09-30","net_assets":-35867,"cash":38579,"average_employees":9},{"financial_date":"2024-09-30","net_assets":-48128,"cash":18721,"average_employees":11},{"financial_date":"2023-09-30","net_assets":6072,"cash":14199},{"financial_date":"2022-09-30","net_assets":42300,"cash":84198},{"financial_date":"2021-09-30","net_assets":59462,"cash":110525}],"officers":{"current":2,"resigned":2,"complete":true,"note":"Names and details of individual officers are on the People page (subscriber-only on this site) and free at Companies House."},"charges":{"total":2,"outstanding":2},"gazette_notices":[],"insolvency_outcome":null,"ai_summary":"Eye Xcel Limited occupies a vulnerable niche position within the UK optometry market as a single-site Boots Opticians franchisee in Stevenage, operating with technically insolvent balance sheet (shareholders' deficit of £35,867) and severe working capital deficiency (net current liabilities of £271,512). While recent modest improvements in cash generation and debt reduction indicate operational viability, the company substantially underperforms sector norms across all key financial metrics and remains dependent upon creditor forbearance for continued going concern status. The structural challenges facing independent optometry practices—online disruption, corporate consolidation, and NHS funding pressure—are compounded in this case by legacy acquisition debt and single-site concentration risk.","website":null,"links":{"page":"https://www.companiesintheuk.co.uk/ltd/eye-xcel","people":"https://www.companiesintheuk.co.uk/company/eye-xcel/people","filing_history":"https://www.companiesintheuk.co.uk/company/eye-xcel/filing-history","companies_house":"https://find-and-update.company-information.service.gov.uk/company/05814814","financials":"https://www.companiesintheuk.co.uk/company/eye-xcel/financial","control":"https://www.companiesintheuk.co.uk/company/eye-xcel/control","charges":"https://www.companiesintheuk.co.uk/company/eye-xcel/charges","ai_analysis":"https://www.companiesintheuk.co.uk/company/eye-xcel/analysis"},"source":"CompaniesInTheUK, from Companies House, The Gazette and other public registers (see /support/about). Cite as: CompaniesInTheUK, https://www.companiesintheuk.co.uk/ltd/eye-xcel"}